Items where authors include "Aldridge, J."

Jump to: Article
Number of items: 12.

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Graves, C.A., Benson, L., Aldridge, J. et al. (13 more authors) (2022) Sedimentary carbon on the continental shelf: Emerging capabilities and research priorities for Blue Carbon. Frontiers in Marine Science, 9. 926215. ISSN 2296-7745

Kousathanas, A. orcid.org/0000-0001-6265-6521, Pairo-Castineira, E. orcid.org/0000-0002-2423-3090, Rawlik, K. orcid.org/0000-0002-0010-370X et al. (2377 more authors) (2022) Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature, 607. pp. 97-103. ISSN 0028-0836

Harris, N., Blackburn, M., Noyes, J. et al. (7 more authors) (2019) Undertaking doctoral research with children and young people with life‐limiting or life‐threatening conditions. Journal of Advanced Nursing, 75 (12). pp. 3183-3185. ISSN 0309-2402

Aldridge, J. orcid.org/0000-0002-9402-8682, Stevens, A. orcid.org/0000-0002-4878-3871 and Barratt, M.J. orcid.org/0000-0002-1015-9379 (2018) Harms, benefits and the policing of cryptomarkets: a response to commentaries. Addiction, 113 (5). pp. 802-804. ISSN 0965-2140

Aldridge, J. orcid.org/0000-0002-9402-8682, Stevens, A. orcid.org/0000-0002-4878-3871 and Barratt, M.J. orcid.org/0000-0002-1015-9379 (2018) Will growth in cryptomarket drug buying increase the harms of illicit drugs? Addiction, 113 (5). pp. 789-796. ISSN 0965-2140

This list was generated on Wed Oct 1 19:52:27 2025 BST.